当前位置: 主页 > 学术产业 > 生物产业

新兴高科技公司成长之途径纳米科技和生物技术公司之案例分析(2)

2005-03-30 11:28 bioguider Nature 阅读 0
核心摘要: 参考文献 见“华侨华人专业人士回国(来华)创业指南”,国务院侨务办公室,二○○三年九月,7~8页及145页。 C. Bai Progress of nanoscience and nanotechnology

参考文献
  1. 见“华侨华人专业人士回国(来华)创业指南”,国务院侨务办公室,二○○三年九月,7~8页及145页。
  2. C. Bai Progress of nanoscience and nanotechnology in China, J. Nanoparticle Res., 3, 251-256 (2001)
  3. R. Paull, J. Wolfe, P. Hebert & M. Sinkula Investing in Nanotechnology, Nature Biotechnology, 21, 1144-1147 (2003)
  4. 2001 International Symp. on Nanomaterials and Technology, Beijing (Jul 2-5, 2001); Shanghai International Nanotechnology Cooperation Symp. (Jul 30 - Aug 1, 2002).
  5. The National High Technology R & D Program (863 Program) was lunched in March 1986 with aim of enhancing China's international capability of R.D. in high Technology.
  6. J.C. Hsiao, X. Ma, T.D. Xiao, and D.E. Reisner Thinking Small in China - Is Nanotech the Next Big Thing?, Nanoparticles 2002, New York, NY, Oct 27-29. 2002.
  7. G.A. Moore, Living on the Fault Line (Harper Business, New York, 2002).
  8. C.M. Christensen, The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail (Harvard Business School Press, Boston, 1997).

致谢∶
作者对Larry Bock允许使用其网上的饼状图及英佛曼和美国纳米材料公司首席执行官David Reisner的有益讨论,谨此致谢。

发表评论